Lantheus weighs potential $7 billion sale, Bloomberg News reports
22/05/2026 21:25
May 22 (Reuters) - Lantheus Holdings LNTH.O is weighing a potential sale after getting a takeover offer from private-equity backed Curium Pharma that could value it at about $7 billion, Bloomberg News reported on Friday, citing people familiar with the matter. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Shilpi Majumdar) ((siddhi.mahatole@thomsonreuters.com;))
Recent news on Lantheus Holdings
See all newsBrief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say
Lantheus falls after report it is considering potential $7 billion sale